DIANA ROMERO: Open Payments
NPI 1053069757 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$579 in 10 payments from 7 companies in 2025. Trend: 2023 $1,890 · 2024 $1,659 · 2025 $579
Food & beverage: $579
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $235 |
| AstraZeneca Pharmaceuticals LP | 1 | $124 |
| SANOFI-AVENTIS U.S. LLC | 1 | $122 |
| Blueprint Medicines Corporation | 1 | $29 |
| Adaptive Biotechnologies Corporation | 1 | $25 |
| Ipsen Biopharmaceuticals, Inc | 1 | $23 |
| ABBVIE INC. | 1 | $22 |
Products named: RYBREVANT, REZUROCK, DARZALEX, AYVAKIT, clonoSEQ, Tazverik.
Industry payments across FL — which companies pay providers there.
